5 Most Valuable Biotech Companies in the World

2. Roche Holding AG (OTC: RHHBY)

Market Cap: $326.101 billion
Number of Hedge Fund Holders: 3

Roche Holding AG (OTC: RHHBY) is a Swiss pharmaceutical and diagnostic business that is based in Basel, Switzerland. It produces pharmaceutical products for cancer, hepatitis, HIV/AIDS, dermatology, anemia, and other major illnesses. Since it was established in 1896, Roche has become one of the leading pharma companies in the world and has developed cutting-edge protein engineering biotech as well as world-class production facilities to become the leading biotech company in terms of sales. For FY 2020, Roche Holding AG (OTC: RHHBY) reported total revenue of $63.5 billion. The company ranks 2^nd amongst the 15 most valuable biotech companies in the world.

Like Pfizer Inc. (NYSE: PFE), Johnson & Johnson (NYSE: JNJ), Novo Nordisk A/S (NYSE: NVO), Moderna, Inc. (NASDAQ: MRNA), and AstraZeneca PLC (NASDAQ: AZN), Roche Holding AG (OTC: RHHBY) is one of the most valuable biotech companies in the world.

In the Q4 2020 Investor Letter, Brown Capital Management highlighted a few stocks, and Roche Holdings AG (OTC:RHHBY) is one of them. This is what the fund said:

“We eliminated Roche Holdings, a Switzerland-based company that is the largest biotech in the world. While the company is on the cutting edge of drug discovery, particularly in cancer-related treatments, it is facing an uncertain growth path and pressure from generics in its mature drugs. Roche has been a positive contributor to the portfolio since its introduction more than a decade ago, and we now take the opportunity to recycle the capital into higher-growth companies.”